These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5926171)

  • 21. DIFFERENCES IN THE METABOLISM OF N-HYDROXY-N-2-FLUORENYLACETAMIDE IN MALE AND FEMALE RATS.
    WEISBURGER EK; GRANTHAM PH; WEISBURGER JH
    Biochemistry; 1964 Jun; 3():808-12. PubMed ID: 14211620
    [No Abstract]   [Full Text] [Related]  

  • 22. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 23. Biosynthesis and reactivity of the glucuronide of N-hydroxy-4-acetylaminobiphenyl.
    Irving CC; Russell LT; Kriek E
    Chem Biol Interact; 1972 Jun; 5(1):37-46. PubMed ID: 4337668
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical carcinogens and RNA.
    Weinstein IB; Grunberger D; Fujimura S; Fink LM
    Cancer Res; 1971 May; 31(5):651-5. PubMed ID: 5582124
    [No Abstract]   [Full Text] [Related]  

  • 25. On protein targets of chemical carcinogens: dissimilar molecular sizes of the principal protein conjugates.
    Sorof S; Young EM; McBride RA; Coffey CB
    Cancer Res; 1970 Jul; 30(7):2029-34. PubMed ID: 4989548
    [No Abstract]   [Full Text] [Related]  

  • 26. Modifications of ribonucleic acid by chemical carcinogens. I. In vitro modification of transfer ribonucleic acid by N-acetoxy-2-acetylaminofluorene.
    Fink LM; Nishimura S; Weinstein IB
    Biochemistry; 1970 Feb; 9(3):496-502. PubMed ID: 4906322
    [No Abstract]   [Full Text] [Related]  

  • 27. Enzymatic activation of the oncogen 3-hydroxyxanthine.
    Stöhrer G; Corbin E; Brown GB
    Cancer Res; 1972 Mar; 32(3):637-42. PubMed ID: 5061313
    [No Abstract]   [Full Text] [Related]  

  • 28. Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid.
    King CM; Phillips B
    Science; 1968 Mar; 159(3821):1351-3. PubMed ID: 5644261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the biosynthesis of flavin nucleotides from 2- 14 C-riboflavin by rat liver and kidney.
    Fazekas AG; Sandor T
    Can J Biochem; 1973 Jun; 51(6):772-82. PubMed ID: 4717063
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines.
    Oesch-Bartlomowicz B; Arens HJ; Richter B; Hengstler JG; Oesch F
    Arch Toxicol; 1997; 71(10):601-11. PubMed ID: 9332696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of chemical carcinogens to nuclear proteins of rat liver.
    Jungmann RA; Schweppe JS
    Cancer Res; 1972 May; 32(5):952-9. PubMed ID: 4622840
    [No Abstract]   [Full Text] [Related]  

  • 32. 2-Acetamidofluorene and 3-methylcholanthrene: differences in binding to rat liver deoxyribonucleic acid in vivo.
    Sporn MB; Dingman CW
    Nature; 1966 Apr; 210(5035):531-2. PubMed ID: 5960519
    [No Abstract]   [Full Text] [Related]  

  • 33. The metabolism of the carcinogen N-(2-fluorenyl) acetamide by liver cell fractions.
    SEAL US; GUTMANN HR
    J Biol Chem; 1959 Mar; 234(3):648-54. PubMed ID: 13641277
    [No Abstract]   [Full Text] [Related]  

  • 34. Transport of carcinogens: rat blood plasma and red cell binding of isotope after N-hydroxy-N-2-fluorenylacetamide.
    Weisburger JH; Grantham PH; Weisburger EK
    Life Sci; 1966 Jan; 5(1):41-5. PubMed ID: 5933654
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 36. The early interference of liver carcinogens with protein synthesis and its possible bearing on the problem of tumor induction.
    Hultin T
    Biochem Pharmacol; 1971 May; 20(5):1009-17. PubMed ID: 5158928
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S; Young EM; McBride RZ; Coffey CB; Luongo L
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract]   [Full Text] [Related]  

  • 38. Labeling of cytoplasmic liver RNA by (6- 14 C)orotic and 5-fluoro(2- 14 C)orotic acids. Effect of several inhibitors.
    Cihák A; Garret C; Pitot HC
    Eur J Biochem; 1973 Apr; 34(1):68-76. PubMed ID: 4121801
    [No Abstract]   [Full Text] [Related]  

  • 39. Fractionation of proteins from 80 s ribosomes of rat liver.
    Staroń K; Domańska B; Toczko K
    Acta Biochim Pol; 1971; 18(3):315-20. PubMed ID: 5129173
    [No Abstract]   [Full Text] [Related]  

  • 40. Depression of enzymic esterification of N-hydroxy-AAF in the liver during aminoazo dye carcinogenesis in the rat.
    Blunck JM; Lees BJ
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):421-9. PubMed ID: 4699475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.